Literature DB >> 25380820

Negative-feedback regulation of the Wnt pathway by conductin/axin2 involves insensitivity to upstream signalling.

Dominic B Bernkopf1, Michel V Hadjihannas1, Jürgen Behrens2.   

Abstract

Axin and conductin (also known as axin2) are structurally related inhibitors of Wnt/β-catenin signalling that promote degradation of β-catenin. Whereas axin is constitutively expressed, conductin is a Wnt target gene implicated in Wnt negative-feedback regulation. Here, we show that axin and conductin differ in their functional interaction with the upstream Wnt pathway component Dvl. Conductin shows reduced binding to Dvl2 compared to axin, and degradation of β-catenin by conductin is only poorly blocked by Dvl2. We propose that insensitivity to Dvl is an important feature of the role of conductin as a negative-feedback regulator of Wnt signalling.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Axin; Conductin; Dvl; Negative feedback; Wnt

Mesh:

Substances:

Year:  2014        PMID: 25380820     DOI: 10.1242/jcs.159145

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  20 in total

1.  Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Authors:  Andrea Martins-da-Silva; Mirella Baroni; Karina Bezerra Salomão; Pablo Ferreira das Chagas; Ricardo Bonfim-Silva; Lenisa Geron; Gustavo Alencastro Veiga Cruzeiro; Wilson Araújo da Silva; Carolina Alves Pereira Corrêa; Carlos Gilberto Carlotti; Rosane Gomes de Paula Queiroz; Suely Kazue Nagahashi Marie; Silvia Regina Brandalise; José Andrés Yunes; Carlos Alberto Scrideli; Elvis Terci Valera; Luiz Gonzaga Tone
Journal:  Cell Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.046

2.  Zooming in on the WNT/CTNNB1 Destruction Complex: Functional Mechanistic Details with Implications for Therapeutic Targeting.

Authors:  Saskia Madelon Ada de Man; Renée van Amerongen
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.

Authors:  Amei Schweigert; Carmen Fischer; Doris Mayr; Dietrich von Schweinitz; Roland Kappler; Jochen Hubertus
Journal:  Pediatr Surg Int       Date:  2016-09-27       Impact factor: 1.827

4.  Loss of Axin2 Causes Ocular Defects During Mouse Eye Development.

Authors:  Ashley Alldredge; Sabine Fuhrmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

5.  MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.

Authors:  Wei Zhou; Yongfeng Li; Shanmiao Gou; Jiongxin Xiong; Heshui Wu; Chunyou Wang; Haijiao Yan; Tao Liu
Journal:  Oncotarget       Date:  2015-11-10

6.  The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.

Authors:  Daniela Kovacs; Emilia Migliano; Luca Muscardin; Vitaliano Silipo; Caterina Catricalà; Mauro Picardo; Barbara Bellei
Journal:  Oncotarget       Date:  2016-07-12

7.  Inactivated Wnt signaling in resveratrol-treated epidermal squamous cancer cells and its biological implication.

Authors:  Zhi-Li Liu; Hong Li; Jia Liu; Mo-Li Wu; Xiao-Yan Chen; Li-Hong Liu; Qian Wang
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

8.  Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation.

Authors:  Tor Espen Thorvaldsen; Nina Marie Pedersen; Eva Maria Wenzel; Harald Stenmark
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

9.  Pgam5 released from damaged mitochondria induces mitochondrial biogenesis via Wnt signaling.

Authors:  Dominic B Bernkopf; Kowcee Jalal; Martina Brückner; Karl X Knaup; Marc Gentzel; Alexandra Schambony; Jürgen Behrens
Journal:  J Cell Biol       Date:  2018-02-08       Impact factor: 10.539

Review 10.  Molecular regulation and pharmacological targeting of the β-catenin destruction complex.

Authors:  Eline C van Kappel; Madelon M Maurice
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.